ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population‐based, nested case–control study
暂无分享,去创建一个
S. Johnsen | T. Larsen | H. SØrensen | H. Larsen | M. Gislum | C. Møller
[1] F. Rosendaal,et al. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden , 2005, Journal of thrombosis and haemostasis : JTH.
[2] J. Heit,et al. Risk factors for venous thromboembolism. , 2003, Clinics in chest medicine.
[3] N. Sattar,et al. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? , 2002, BMJ : British Medical Journal.
[4] E. Taioli,et al. Inherited Thrombophilia and First Venous Thromboembolism during Pregnancy and Puerperium , 2002, Thrombosis and Haemostasis.
[5] E. Grandone,et al. Risk of Pregnancy-related Venous Thrombosis in Carriers of Severe Inherited Thrombophilia , 2001, Thrombosis and Haemostasis.
[6] A. Eldor. Thrombophilia, Thrombosis and Pregnancy , 2001, Thrombosis and Haemostasis.
[7] L. Almasy,et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[8] I. Juhan-vague,et al. ABO Blood Group and Risk of Venous Thrombosis in Heterozygous Carriers of Factor V Leiden , 2000, Thrombosis and Haemostasis.
[9] T. F. Andersen,et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.
[10] I. Greer. Thrombosis in pregnancy: maternal and fetal issues , 1999, The Lancet.
[11] A. Many,et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. , 1999, The New England journal of medicine.
[12] M. Margaglione,et al. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. , 1998, American journal of obstetrics and gynecology.
[13] G. Leftheriotis,et al. Diagnostic strategy in deep-vein thrombosis , 1998, The Lancet.
[14] G. B. Petersen,et al. The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns. , 1998, Thrombosis research.
[15] K. Ward,et al. The incidence of the factor V Leiden mutation in an obstetricpopulation and its relationship to deep vein thrombosis , 1997, American journal of obstetrics and gynecology.
[16] H. Sørensen,et al. Danish health registries. A valuable tool in medical research. , 1996, Danish medical bulletin.
[17] D. Slosman,et al. Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study. , 1996, Archives of internal medicine.
[18] J. Vandenbroucke,et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.
[19] G. Raskob,et al. Venous thromboembolic disease , 1991, Current opinion in cardiology.
[20] A A Connolly,et al. Deep vein thrombosis. , 1988, BMJ.
[21] I. Peake. International Society on Thrombosis and Haemostasis , 1974, Thrombosis and Haemostasis.
[22] M. Bates. Venous thromboembolic disease and ABO blood type. , 1971, Lancet.
[23] M. Langman,et al. ABO blood-groups and venous thromboembolic disease. , 1970, Lancet.
[24] S. Shapiro,et al. Venous thromboembolic disease and ABO blood type. A cooperative study. , 1969, Lancet.
[25] B. Yawn,et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. , 2001, American journal of obstetrics and gynecology.